Nuvation Bio to Acquire AnHeart Therapeutics in All Stock Transaction

New York, NY, March 25, 2024 – Nuvation Bio Inc. (NYSE: NUVB), a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates, and AnHeart Therapeutics Ltd. (AnHeart), a global clinical-stage biopharmaceutical company developing novel precision therapies for people with cancer, today…Read More

Read More
Nektar Therapeutics Announces $30 Million Private Placement Financing with TCGX

SAN FRANCISCO, March 4, 2024 /PRNewswire/ — Nektar Therapeutics (Nasdaq: NKTR), a biotechnology company developing medicines for the treatment of auto-immune disorders, today announced that it has entered into a securities purchase agreement with TCGX, an institutional accredited investor, to sell securities in a private placement financing (the “PIPE”) for gross…Read More

Read More
Adverum Biotechnologies Announces $127.5 Million Private Placement Financing

REDWOOD CITY, Calif., Feb. 05, 2024 (GLOBE NEWSWIRE) — Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage company that aims to establish gene therapy as a new standard of care for highly prevalent ocular diseases, today announced that it has agreed to sell approximately 106.25 million shares of its common stock…Read More

Read More
Zum Raises $140M in E Round Led by GIC

REDWOOD CITY, Calif., Jan. 31, 2024 – Zūm, the leading provider of modern student transportation, today announced a $140 million Series E funding round. This new funding round was led by GIC, a leading global investment firm. Climate Investment, a decarbonization investor, and existing investors including Sequoia and SoftBank Vision Fund 2 also participated in…Read More

Read More
LogicMark Launches 2 Products, Care Village Platform and Web App

FLG partner Mark Archer, CFO at LogicMark (Nasdaq: LGMK) was delighted to help ring the market closing bell from Nasdaq’s headquarters in NYC as the company celebrated the December 2023 launch of its two new products, a SaaS medical mobile alert device (the Freedom Alert Plus) for the B-to-C market of seniors and…Read More

Read More